https://pharmatlas.org/ 2026-04-06T11:08:23+00:00 https://pharmatlas.org/ https://pharmatlas.org/lib/exe/fetch.php?media=logo.png text/html 2026-02-12T20:04:59+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:beclomethasone&rev=1770926699&do=diff Beclomethasone Classification * Inhaled/intranasal glucocorticoid Parent class: * Corticosteroids ---------- Clinical Uses * Asthma * Allergic rhinitis ---------- Clinical Pearls * One of the earlier inhaled corticosteroids. text/html 2026-02-12T20:07:13+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:betamethasone&rev=1770926833&do=diff Betamethasone Classification * Long-acting systemic glucocorticoid * High-potency corticosteroid * No mineralocorticoid activity Parent class: * Corticosteroids ---------- Mechanism of Action Binds intracellular glucocorticoid receptors → alters gene transcription → strong suppression of inflammatory cytokines and eicosanoid production. text/html 2026-02-12T20:04:03+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:budesonide&rev=1770926643&do=diff Budesonide Classification * Glucocorticoid * Inhaled and GI-targeted formulations Parent class: * Corticosteroids ---------- Clinical Uses Inhaled: * Asthma GI-targeted: * Inflammatory Bowel Disease ---------- Clinical Pearls * High first-pass metabolism reduces systemic effects (GI formulation). text/html 2026-02-12T20:05:12+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:ciclesonide&rev=1770926712&do=diff Ciclesonide Classification * Inhaled glucocorticoid * Prodrug activated in lungs Parent class: * Corticosteroids ---------- Clinical Pearls * Reduced oropharyngeal side effects due to prodrug activation. text/html 2026-02-12T20:07:31+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:clobetasol&rev=1770926851&do=diff Clobetasol Classification * Very high-potency topical glucocorticoid (Class I) Parent class: * Corticosteroids ---------- Mechanism of Action Topical glucocorticoid receptor activation → decreased local cytokine production → reduced inflammation and immune cell activity. text/html 2026-02-12T20:05:38+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:cortisone&rev=1770926738&do=diff Cortisone Classification * Short-acting glucocorticoid Parent class: * Corticosteroids ---------- Key Point Converted in liver to hydrocortisone. Less commonly used clinically. text/html 2026-02-12T20:06:23+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:desonide&rev=1770926783&do=diff Desonide Classification * Low-potency topical glucocorticoid Parent class: * Corticosteroids ---------- Clinical Use * Mild dermatitis * Face or sensitive skin areas text/html 2026-02-12T19:54:33+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:dexamethasone&rev=1770926073&do=diff Dexamethasone Classification * Long-acting systemic glucocorticoid * High-potency corticosteroid Parent class: * Corticosteroids ---------- Mechanism of Action Dexamethasone: * Binds intracellular glucocorticoid receptors * Alters gene transcription text/html 2026-02-12T20:05:54+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:fludrocortisone&rev=1770926754&do=diff Fludrocortisone Classification * Mineralocorticoid Parent class: * Corticosteroids ---------- Mechanism Acts on renal mineralocorticoid receptors: * ↑ Sodium retention * ↑ Water retention * ↑ Potassium excretion ---------- Clinical Use * text/html 2026-02-12T20:05:27+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:flunisolide&rev=1770926727&do=diff Flunisolide Classification * Inhaled/intranasal glucocorticoid Parent class: * Corticosteroids ---------- Clinical Use * Asthma * Allergic rhinitis text/html 2026-02-12T20:06:09+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:fluocinonide&rev=1770926769&do=diff Fluocinonide Classification * High-potency topical glucocorticoid Parent class: * Corticosteroids text/html 2026-02-12T20:04:18+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:fluticasone&rev=1770926658&do=diff Fluticasone Classification * High-potency inhaled/intranasal glucocorticoid Parent class: * Corticosteroids ---------- Clinical Uses * Asthma * Allergic Rhinitis ---------- Clinical Pearls * Minimal systemic absorption when inhaled. * First-line for allergic rhinitis congestion. text/html 2026-02-12T20:02:57+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:hydrocortisone&rev=1770926577&do=diff Hydrocortisone Classification * Short-acting systemic glucocorticoid * Also available topical and rectal Parent class: * Corticosteroids ---------- Mechanism of Action Binds intracellular glucocorticoid receptor → alters gene transcription → broad anti-inflammatory effects. text/html 2026-02-12T20:03:37+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:methylprednisolone&rev=1770926617&do=diff Methylprednisolone Classification * Intermediate-acting glucocorticoid * Minimal mineralocorticoid activity Parent class: * Corticosteroids ---------- Clinical Uses * Severe asthma exacerbation * Autoimmune disease * IV pulse therapy (e.g., MS flare) text/html 2026-02-12T20:04:39+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:mometasone&rev=1770926679&do=diff Mometasone Classification * High-potency inhaled/intranasal glucocorticoid Parent class: * Corticosteroids ---------- Clinical Uses * Asthma * Allergic rhinitis ---------- Clinical Pearls * Long pulmonary retention. * Low systemic bioavailability. text/html 2026-02-12T20:07:49+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:prednisolone&rev=1770926869&do=diff Prednisolone Classification * Intermediate-acting systemic glucocorticoid * Active metabolite of prednisone Parent class: * Corticosteroids ---------- Mechanism of Action Binds intracellular glucocorticoid receptor → alters gene transcription → suppresses inflammatory cytokines and immune activation. text/html 2026-02-12T20:03:22+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:prednisone&rev=1770926602&do=diff Prednisolone Classification * Intermediate-acting glucocorticoid * Active form of prednisone Parent class: * Corticosteroids ---------- Key Point Prednisolone is the active metabolite of Prednisone. Preferred in severe hepatic impairment. ---------- Clinical Uses text/html 2026-02-12T20:03:49+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:drugs:triamcinolone&rev=1770926629&do=diff Triamcinolone Classification * Intermediate-acting glucocorticoid * No mineralocorticoid activity Parent class: * Corticosteroids ---------- Formulations * Topical * Intranasal * Intra-articular injection ---------- Clinical Uses * Dermatitis